​In early-stage life sciences, where breakthrough innovation meets financial reality, raising capital is not just a milestone—it is a continuous, high-stakes process. The ability to secure the right investment, on the right terms, at the right time determines whether a company can sustain its research, reach critical milestones, and scale successfully.
​
The Chief Financial Officer (CFO) plays a central role in shaping a company’s financial strategy, ensuring that capital-raising efforts are strategic, well-executed, and aligned with long-term growth objectives.

​Calculating Capital Needs:
How Much, When, and Under What Terms?

A successful fundraising strategy begins with a precise understanding of capital needs. How much funding is required? When will it be needed? How will it be allocated, and what returns will investors expect?
An experienced CFO:
• Develops detailed financial models to determine capital requirements.

• Builds comprehensive forecasts that align funding needs with R&D, operations, and market strategy.

• Ensures investment is structured in a way that supports long-term growth without excessive dilution.
The CFO’s expertise is crucial in crafting a pitch deck that presents a clear, data-driven investment case. Investors want to see precisely how capital will be deployed, which milestones will be reached, and how the company’s valuation will increase. These benchmarks serve not only as progress indicators but also as enticing incentives for investor participation.
Beyond the pitch deck, a well-structured data room is essential. A CFO ensures that every assumption in the financial projections is backed by hard data, presented in a format that investors can quickly assess with confidence.
Crafting a Compelling Investment Narrative

Raising capital is as much about storytelling as it is about numbers. Investors hear countless pitches from life science startups—what makes yours stand out?
A skilled CFO:
  • Shapes a compelling investment narrative that positions the company as a unique, high-value opportunity.
 
  • Connects financial projections to scientific breakthroughs, demonstrating how research and development translate into market success.
 
  • Ensures that the investment story aligns with current market trends and investor interests, increasing the likelihood of securing funding.​ ​
​A compelling, well-structured investment case is what separates companies that attract strong investors from those that struggle to secure funding.
​Identifying and Engaging the Right Investors

While the CEO leads investor presentations, the CFO drives the investor engagement process. Every moment a CEO spends seeking investors instead of leading the company is a missed opportunity to focus on operations, product development, and strategic execution.
A well-connected CFO:
  • Identifies and targets investors who are the best fit for the company’s stage, sector, and funding needs.
​
  • Maintains relationships with key financial institutions, venture capital firms, and strategic partners.

  • Ensures investor meetings are strategically timed to maximize impact.
During investor presentations, while the CEO focuses on the company’s vision, the CFO anchors the discussion with hard financial data and market validation. They are prepared to answer difficult financial questions on the spot, giving investors confidence in the company’s financial and operational planning.
Beyond fundraising, the CFO serves as the company’s primary financial ambassador, maintaining ongoing investor relations to strengthen long-term financial partnerships.
​Negotiating Investment Terms
and Securing Favorable Agreements

Raising capital is not just about securing funding—it is about securing the right funding under the right terms. An experienced CFO acts as a safeguard, ensuring that financing structures are strategic rather than reactionary.
A skilled CFO:
  • Negotiates investment terms that protect company control and minimize unnecessary dilution.
 
  • Balances investor expectations with company priorities, ensuring financing terms support long-term success rather than short-term liquidity.
​
  • Explores alternative funding models, such as non-dilutive funding, partnerships, and structured financing, to expand available capital options.
In sum, the role of the life science CFO in securing early-stage capital is multifaceted and critical. It requires a confluence of  expansive experience, extensive professional skills, comprehensive industry knowledge, strategic insight, robust professional relationships, and negotiation prowess.
RAISING CAPITAL FOR EARLY-STAGE BIOTECHS & THE CFO PART 1
Our Network
​We believe we have the most extensive proprietary network of life science CFOs and senior finance executives in the executive search industry.

For over 35 years, we have cultivated longstanding relationships with the top-tier CFOs specializing in early-stage life science companies. These highly accomplished financial leaders bring with them the expertise and connections needed to execute key strategies, including:
​
• Joint ventures and strategic alliances
• Mergers & acquisitions
• Public and private offerings
• Exit strategies

Our exclusive specialization and deep industry expertise eliminate uncertainty and risk, ensuring that each CFO we place is the right fit for your company’s strategic objectives, challenges and corporate culture.